BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24148183)

  • 1. Engineering precursor metabolite pools for increasing production of antitumor mithramycins in Streptomyces argillaceus.
    Zabala D; Braña AF; Flórez AB; Salas JA; Méndez C
    Metab Eng; 2013 Nov; 20():187-97. PubMed ID: 24148183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK: three new products generated in the mithramycin producer Streptomyces argillaceus through combinatorial biosynthesis.
    Remsing LL; González AM; Nur-e-Alam M; Fernández-Lozano MJ; Braña AF; Rix U; Oliveira MA; Méndez C; Salas JA; Rohr J
    J Am Chem Soc; 2003 May; 125(19):5745-53. PubMed ID: 12733914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterologous reconstitution of the biosynthesis pathway for 4-demethyl-premithramycinone, the aglycon of antitumor polyketide mithramycin.
    Zabala D; Song L; Dashti Y; Challis GL; Salas JA; Méndez C
    Microb Cell Fact; 2020 May; 19(1):111. PubMed ID: 32448325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of two genes from Streptomyces argillaceus encoding glycosyltransferases involved in transfer of a disaccharide during biosynthesis of the antitumor drug mithramycin.
    Fernández E; Weissbach U; Sánchez Reillo C; Braña AF; Méndez C; Rohr J; Salas JA
    J Bacteriol; 1998 Sep; 180(18):4929-37. PubMed ID: 9733697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketopremithramycins and ketomithramycins, four new aureolic acid-type compounds obtained upon inactivation of two genes involved in the biosynthesis of the deoxysugar moieties of the antitumor drug mithramycin by Streptomyces argillaceus, reveal novel insights into post-PKS tailoring steps of the mithramycin biosynthetic pathway.
    Remsing LL; Garcia-Bernardo J; Gonzalez A; Künzel E; Rix U; Braña AF; Bearden DW; Méndez C; Salas JA; Rohr J
    J Am Chem Soc; 2002 Feb; 124(8):1606-14. PubMed ID: 11853433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and insertional inactivation of Streptomyces argillaceus genes involved in the earliest steps of biosynthesis of the sugar moieties of the antitumor polyketide mithramycin.
    Lombó F; Siems K; Braña AF; Méndez C; Bindseil K; Salas JA
    J Bacteriol; 1997 May; 179(10):3354-7. PubMed ID: 9150235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Streptomyces argillaceus genes encoding a polyketide synthase involved in the biosynthesis of the antitumor mithramycin.
    Lombó F; Blanco G; Fernández E; Méndez C; Salas JA
    Gene; 1996 Jun; 172(1):87-91. PubMed ID: 8654997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertional inactivation of mtrX and mtrY genes from the mithramycin gene cluster affects production and growth of the producer organism Streptomyces argillaceus.
    Garcia-Bernardo J; Braña AF; Méndez C; Salas JA
    FEMS Microbiol Lett; 2000 May; 186(1):61-5. PubMed ID: 10779713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of two chromosomal regions adjacent to genes for a type II polyketide synthase involved in the biosynthesis of the antitumor polyketide mithramycin in Streptomyces argillaceus.
    Prado L; Lombó F; Braña AF; Méndez C; Rohr J; Salas JA
    Mol Gen Genet; 1999 Mar; 261(2):216-25. PubMed ID: 10102355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative cleavage of premithramycin B is one of the last steps in the biosynthesis of the antitumor drug mithramycin.
    Prado L; Fernández E; Weissbach U; Blanco G; Quirós LM; Braña AF; Méndez C; Rohr J; Salas JA
    Chem Biol; 1999 Jan; 6(1):19-30. PubMed ID: 9889148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of two glycosyltransferases involved in early glycosylation steps during biosynthesis of the antitumor polyketide mithramycin by Streptomyces argillaceus.
    Blanco G; Fernández E; Fernández MJ; Braña AF; Weissbach U; Künzel E; Rohr J; Méndez C; Salas JA
    Mol Gen Genet; 2000 Jan; 262(6):991-1000. PubMed ID: 10660060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the Chemical Diversity of the Antitumoral Compound Mithramycin by Combinatorial Biosynthesis and Biocatalysis: The Quest for Mithralogs with Improved Therapeutic Window.
    Méndez C; González-Sabín J; Morís F; Salas JA
    Planta Med; 2015 Oct; 81(15):1326-38. PubMed ID: 26393942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mithramycin analogues generated by combinatorial biosynthesis show improved bioactivity.
    Baig I; Perez M; Braña AF; Gomathinayagam R; Damodaran C; Salas JA; Méndez C; Rohr J
    J Nat Prod; 2008 Feb; 71(2):199-207. PubMed ID: 18197601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of two polyketide methyltransferases involved in the biosynthesis of the antitumor drug mithramycin by Streptomyces argillaceus.
    Lozano MJ; Remsing LL; Quirós LM; Braña AF; Fernández E; Sánchez C; Méndez C; Rohr J; Salas JA
    J Biol Chem; 2000 Feb; 275(5):3065-74. PubMed ID: 10652287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mithramycin gene cluster of Streptomyces argillaceus contains a positive regulatory gene and two repeated DNA sequences that are located at both ends of the cluster.
    Lombó F; Braña AF; Méndez C; Salas JA
    J Bacteriol; 1999 Jan; 181(2):642-7. PubMed ID: 9882681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of mithramycin biosynthesis in Streptomyces argillaceus: dual role as activator and repressor of the PadR-like regulator MtrY.
    Flórez AB; Álvarez S; Zabala D; Braña AF; Salas JA; Méndez C
    Microbiology (Reading); 2015 Feb; 161(Pt 2):272-284. PubMed ID: 25416691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mtmVUC genes of the mithramycin gene cluster in Streptomyces argillaceus are involved in the biosynthesis of the sugar moieties.
    González A; Remsing LL; Lombó F; Fernández MJ; Prado L; Braña AF; Künzel E; Rohr J; Méndez C; Salas JA
    Mol Gen Genet; 2001 Feb; 264(6):827-35. PubMed ID: 11254130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of new derivatives of the antitumor antibiotic mithramycin by altering the glycosylation pattern through combinatorial biosynthesis.
    Pérez M; Baig I; Braña AF; Salas JA; Rohr J; Méndez C
    Chembiochem; 2008 Sep; 9(14):2295-304. PubMed ID: 18756551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mithramycin analogue with high antitumor activity and less toxicity generated by combinatorial biosynthesis.
    Núñez LE; Nybo SE; González-Sabín J; Pérez M; Menéndez N; Braña AF; Shaaban KA; He M; Morís F; Salas JA; Rohr J; Méndez C
    J Med Chem; 2012 Jun; 55(12):5813-25. PubMed ID: 22578073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing antibiotic production yields by favoring the biosynthesis of precursor metabolites glucose-1-phosphate and/or malonyl-CoA in Streptomyces producer strains.
    Zabala D; Braña AF; Salas JA; Méndez C
    J Antibiot (Tokyo); 2016 Mar; 69(3):179-82. PubMed ID: 26464013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.